Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ioanna Gouni-Berthold, MD
University of Cologne
Principal Investigator - Laszlo Koranyi, MD
Drug Research Center, Balatonfured, Hungary
Principal Investigator - Peter Damsbo, MD
Kinexum LLC, Harper's Ferry, WV, USA
Study Director - Robert Ratner, MD
Medstar Research Institute, Hyattsville, Maryland, USA
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Diabetespraxis Bad Mergentheim
Bad Mergentheim, Germany
- Universitätsklinikum Köln
Cologne, Germany
- Praxis Dr. Schätzl
Großheirath-Rossach, Germany
- Schwerpunktpraxis Diabetes
Neuwied, Germany
- Diabetologische Schwerpunktpraxis
Siegen, Germany
- Drug Research Center Hungary Kft.
Balatonfüred, Hungary
- Semmelweis University 2nd Clinic for Internal Medicine
Budapest, Hungary
- Petz Aladar Country Teaching Hospital, Dept of Diabetology and Metabolism
Győr, Hungary
- Dr. Bugyi Istvan Hospital, Diabetology Outpatient Clinic
Szentes, Hungary
- Zala County Hospital Department of Diabetology
Zalaegerszeg, Hungary
- Andrew J. Lewin Medical Corporation Dba National Research Institute
Los Angeles, California, United States
- Center for Clinical Trials, Llc.
Paramount, California, United States
- Orange County Research Center
Tustin, California, United States
- Creekside Endocrine Associates Pc
Denver, Colorado, United States
- Clinical Research of South Florida
Coral Gables, Florida, United States
- Metabolic Research Institute, Inc.
West Palm Beach, Florida, United States
- Atlanta Pharmaceutical Research
Decatur, Georgia, United States
- Icct Research International, Inc.
Chicago, Illinois, United States
- Medstar Health Research Institute
Hyattsville, Maryland, United States
- the Center for Pharmaceutical Research, P.C.
Kansas City, Missouri, United States
- Nevada Alliance Against Diabetes
Las Vegas, Nevada, United States
- New Hanover Medical Research
Wilmington, North Carolina, United States
- Piedmont Medical Research, Llc.
Winston-Salem, North Carolina, United States
- Upstate Pharmaceutical Research
Greenville, South Carolina, United States
- Mountain View Clinical Research
Greer, South Carolina, United States
- Southeastern Research Associates, Inc.
Taylors, South Carolina, United States
- Athens Medical Group
Athens, Tennessee, United States
- Juno Research, Llc.
Houston, Texas, United States
- Juno Research, Llc.
Katy, Texas, United States
- Cetero Research-San Antonio
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2010
- Primary completion
- 31 Aug 2011
- Completion
- 31 Oct 2011
- Last update posted
- 29 Sept 2014
- Registered enrollment
- 196
- Registry id
- NCT01069965
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.